Pevec et al., 2010) and worsening, as well as immunosuppression (Sikiric et al., 2003)
Kinnunen, S., Hyypp, S., Lehmuskero, A., Oksala, N., Menp, P., Hnninen, O., & Atalay, M
Key Findings The GLP-1 trend data shows a large overall increase in the number of prescriptions of GLP-1s for weight loss, from just over 20,000 prescriptions in 2018 to over 700,000 in 2023
You select your dose, press the button, and the pen injects exactly 0.5 ml regardless of the dose
Peptide therapy for body composition may be appropriate for patients who: Have high visceral fat on imaging Plateaued with traditional weight loss Lost muscle mass on GLP-1 therapy Show low-normal IGF-1 Want a longevity-based metabolic strategy Are healthy individuals seeking to optimize body composition and longevity, under medical supervision It is not a quick fix
Tracking should reduce mental load, not add to it